Transferrin-Conjugated, Camptothecin-Bearing Dendrimersomes Entrapping Docetaxel as a Dual-Drug Nanoplatform for Targeted Prostate Cancer Therapy.

Albatsh M, Al-Quraishi Z, Laskar P, Somani S, Irving C, Mackenzie GR, Woods S, Roberts CW, Mullin M, Dufès C

Open source

DOI
10.3390/pharmaceutics18080959
Published
2026 Aug 4
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18080959,
  title = {Transferrin-Conjugated, Camptothecin-Bearing Dendrimersomes Entrapping Docetaxel as a Dual-Drug Nanoplatform for Targeted Prostate Cancer Therapy.},
  author = {Albatsh M and Al-Quraishi Z and Laskar P and Somani S and Irving C and Mackenzie GR and Woods S and Roberts CW and Mullin M and Dufès C},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18080959},
  url = {https://doi.org/10.3390/pharmaceutics18080959}
}

RIS

TY  - JOUR
TI  - Transferrin-Conjugated, Camptothecin-Bearing Dendrimersomes Entrapping Docetaxel as a Dual-Drug Nanoplatform for Targeted Prostate Cancer Therapy.
AU  - Albatsh M
AU  - Al-Quraishi Z
AU  - Laskar P
AU  - Somani S
AU  - Irving C
AU  - Mackenzie GR
AU  - Woods S
AU  - Roberts CW
AU  - Mullin M
AU  - Dufès C
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18080959
UR  - https://doi.org/10.3390/pharmaceutics18080959
ER  -

APA

M, A., Z, A., P, L., S, S., C, I., GR, M., S, W., CW, R., M, M., & C, D. (2026). Transferrin-Conjugated, Camptothecin-Bearing Dendrimersomes Entrapping Docetaxel as a Dual-Drug Nanoplatform for Targeted Prostate Cancer Therapy.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18080959

Source records